Radium Ra 223 Dichloride: 82 Clinical Trials, Page 1 of 9

Hide Studies Not Open or Pending


Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

Condition(s):Anatomic Stage IV Breast Cancer AJCC v8; Hormone Receptor Positive Breast Adenocarcinoma; Metastatic Breast Carcinoma; Metastatic HER2 Negative Breast Adenocarcinoma; Metastatic Malignant Neoplasm in the Bone; Metastatic Triple-Negative Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8Last Updated:January 13, 2021Recruiting


Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study

Condition(s):Advanced Renal Cell Carcinoma; Chromophobe Renal Cell Carcinoma; Clear Cell Renal Cell Carcinoma; Collecting Duct Carcinoma; Kidney Medullary Carcinoma; Metastatic Malignant Neoplasm in the Bone; Papillary Renal Cell Carcinoma; Stage IV Renal Cell Cancer AJCC v8; Unclassified Renal Cell CarcinomaLast Updated:January 15, 2021Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.